As global growth slows, UBS advises investors to focus on defensive sectors like utilities and pharmaceuticals. With declining global manufacturing PMI and U.S. factory activity, UBS recommends Constellation Energy and Eli Lilly as strong buys, anticipating growth despite economic challenges.